Showing 1091-1100 of 3098 results for "".
Curbside Consults in Neurology: Accompany Courtesy With Caution
https://practicalneurology.com/columns/practice-management/curbside-consults-in-neurology-accompany-courtesy-with-caution/30847/Clinicians must exercise caution when providing “unofficial” advice for individuals not under their care.In-Focus: Charting a New Course to Seizure Freedom
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/in-focus-charting-a-new-course-to-seizure-freedom/30315/As Treatment Options Expand, Researchers Continue to Explore the Basis of MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/as-treatment-options-expand-researchers-continue-to-explore-the-basis-of-ms/30601/New treatments have emerged and others are expected. What have changes meant for patient care?Detecting Atrial Fibrillation: How Long Should Patients Be Monitored?
https://practicalneurology.com/diseases-diagnoses/stroke/detecting-atrial-fibrillation-how-long-should-patients-be-monitored/30453/Gathering evidence appears to show significant benefit for long-term monitoring in atrial fibrillation detection.New Directions in the Management of Focal Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/new-directions-in-the-management-of-focal-epilepsy/30431/Conference Digest: Insights from Summer Neurology Meetings
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/conference-digest-insights-from-summer-neurology-meetings/30335/Managing Agitation and Aggression in Alzheimer's Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/managing-agitation-and-aggression-in-alzheimers-disease/30507/Physicians should consider a range of both pharmacologic and non-pharmacologic interventions when addressing agitation.Discontinuing Disease-Modifying Therapy in Multiple Sclerosis: Should You Have an Exit Strategy?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/discontinuing-disease-modifying-therapy-in-multiple-sclerosis-should-you-have-an-exit-strategy/30303/Two experts sound off on the implications of indefinite treatment and whether DMTs should be stopped.Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/special-report-2025-drug-device-approvals/54790/A quick reference for the drugs and devices for neurologic conditions that received approval or clearance notice from the Food and Drug Administration last year.News
https://practicalneurology.com/diseases-diagnoses/stroke/news/30271/New Guidance for Stroke, Opioids and RLS, 10,000th Enrollee in Parkinson's Outcomes Project, Lower Risk of Ischemic Stroke with Rivaroxaban, Sublingual Riluzole Bioequivalence, Clinical Headache Trials